Aytu Biopharma Inc (AYTU)

$2.20 +0.02 (0.92%)
Market Cap 19.75M
Revenue (ttm) 81.00M
Net Income (ttm) -15.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -19.56%
Debt to Equity Ratio 0.61
Volume 94,600
Avg Vol 163,430
Day's Range N/A - N/A
Shares Out 8.98M
Stochastic %K 39%
Beta 0.13
Analysts Strong Sell
Price Target $9.33

Company Profile

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above, and Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old. It also provides pedia...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 720 437 6580
Website: aytubio.com
Address:
Denver Corporate Center III, Suite 920 7900 East Union Avenue, Denver, United States
OptionSpark
OptionSpark Aug. 23 at 6:48 AM
$AYTU Aytu BioPharma Inc is a specialty pharma company with commercial execution challenges
0 · Reply
OptionSpark
OptionSpark Aug. 23 at 6:33 AM
$AYTU Aytu BioPharma Inc is a specialty pharma company with commercial execution challenges
0 · Reply
Alice_in_Dollarland
Alice_in_Dollarland Aug. 22 at 3:31 PM
$ELTP Upcoming catalysts include ANDA filing and FDA approval for a generic Eliquis ( the number #1 oral anticoagulant) prescribed globally. Last quarter's revenue was 40 million, an increase of 112% from a comparable quarter last year. Annual revenue 84 million, up 48 % from the last fiscal year. $AYTU $IINN $SIGA
0 · Reply
Alice_in_Dollarland
Alice_in_Dollarland Aug. 21 at 5:56 PM
$AYTU more interested in the drug for major depression.
0 · Reply
anotherbullrun
anotherbullrun Aug. 21 at 5:07 PM
$AYTU guys dont worry healight is coming soon
0 · Reply
Alice_in_Dollarland
Alice_in_Dollarland Aug. 21 at 4:57 PM
$AYTU Bearish board, but after looking over a couple of things...I'm in.
0 · Reply
redbugs
redbugs Aug. 16 at 2:26 AM
$AYTU Question please...I am not a shareholder of aytu having sold years ago as I saw this company was a dud going nowhere but down. However I am still holding in my fidelity account some CVRs related to the merger with Innovis. My understanding was these CVRs have expired. IS this true? If so why have they not been removed from my fidelity account?
1 · Reply
Alain_Simard
Alain_Simard Aug. 14 at 11:35 PM
$AYTU and there it is… AYTU is back to where it was a month ago… the only that sticks around here are dropping share prices
0 · Reply
Telorino
Telorino Aug. 12 at 3:45 PM
$AYTU POS only red in a sea of green… Everything ripping to ATH, except this mother f…er heading to R/S! You could literally throw a dart and pick anything better than A2! Where’re the pumpers?
0 · Reply
ZealTradingIsBack
ZealTradingIsBack Aug. 5 at 9:11 AM
$AYTU Used to be a holder from Covid Days and believed in Heal Light. Someone I know still holds and says they keep doing offerings. 🤷‍♂️ GLTA
0 · Reply
Latest News on AYTU
Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)

Jun 25, 2025, 8:00 AM EDT - 2 months ago

Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)

Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)

Jun 23, 2025, 8:00 AM EDT - 2 months ago

Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)

Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan

Jun 9, 2025, 4:30 PM EDT - 2 months ago

Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan

Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock

Jun 6, 2025, 8:01 AM EDT - 2 months ago

Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock

Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States

Jun 6, 2025, 8:00 AM EDT - 2 months ago

Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States

Aytu BioPharma, Inc. (Aytu ) Q3 2025 Earnings Call Transcript

May 14, 2025, 8:29 PM EDT - 3 months ago

Aytu BioPharma, Inc. (Aytu ) Q3 2025 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results

May 14, 2025, 4:05 PM EDT - 3 months ago

Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results

Aytu BioPharma to Report Fiscal 2025 Third Quarter Operational and Financial Results on May 14, 2025

May 7, 2025, 4:15 PM EDT - 3 months ago

Aytu BioPharma to Report Fiscal 2025 Third Quarter Operational and Financial Results on May 14, 2025

Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Apr 21, 2025, 4:05 PM EDT - 4 months ago

Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Aytu BioPharma, Inc. (AYTU) Q2 2025 Earnings Call Transcript

Feb 12, 2025, 6:27 PM EST - 6 months ago

Aytu BioPharma, Inc. (AYTU) Q2 2025 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results

Feb 12, 2025, 4:03 PM EST - 6 months ago

Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results

Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

Feb 5, 2025, 5:50 PM EST - 7 months ago

Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Jan 6, 2025, 9:00 AM EST - 8 months ago

Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Aytu BioPharma Disclosure Notification

Dec 3, 2024, 11:45 PM EST - 9 months ago

Aytu BioPharma Disclosure Notification

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

Nov 22, 2024, 9:00 AM EST - 9 months ago

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript

Nov 13, 2024, 7:25 PM EST - 10 months ago

Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results

Nov 13, 2024, 4:05 PM EST - 10 months ago

Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results

Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024

Nov 6, 2024, 5:20 PM EST - 10 months ago

Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024

Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 14, 2024, 4:15 PM EDT - 11 months ago

Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit

Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada

Oct 1, 2024, 8:00 AM EDT - 11 months ago

Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada

Aytu BioPharma, Inc. (AYTU) Q4 2024 Earnings Call Transcript

Sep 26, 2024, 6:51 PM EDT - 11 months ago

Aytu BioPharma, Inc. (AYTU) Q4 2024 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results

Sep 26, 2024, 4:15 PM EDT - 11 months ago

Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results

Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024

Sep 19, 2024, 5:30 PM EDT - 1 year ago

Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

Aug 8, 2024, 5:20 PM EDT - 1 year ago

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

Aug 6, 2024, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms

Jun 18, 2024, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms

Aytu BioPharma, Inc. (AYTU) Q3 2024 Earnings Call Transcript

May 15, 2024, 8:28 PM EDT - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q3 2024 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results

May 15, 2024, 4:05 PM EDT - 1 year ago

Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

May 8, 2024, 4:15 PM EDT - 1 year ago

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024

Apr 3, 2024, 9:00 AM EDT - 1 year ago

Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024

Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript

Feb 14, 2024, 10:52 PM EST - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

Feb 14, 2024, 4:05 PM EST - 1 year ago

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024

Feb 7, 2024, 4:15 PM EST - 1 year ago

Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Jan 23, 2024, 9:00 AM EST - 1 year ago

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

Nov 30, 2023, 8:00 AM EST - 1 year ago

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

Aytu BioPharma, Inc. (AYTU) Q1 2024 Earnings Call Transcript

Nov 14, 2023, 7:30 PM EST - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q1 2024 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Nov 14, 2023, 4:05 PM EST - 1 year ago

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

Nov 8, 2023, 8:30 AM EST - 1 year ago

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023

Nov 7, 2023, 4:15 PM EST - 1 year ago

Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023

Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Oct 26, 2023, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023

Oct 9, 2023, 4:15 PM EDT - 2 years ago

Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023

Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript

Sep 27, 2023, 7:01 PM EDT - 2 years ago

Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript

Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023

Sep 27, 2023, 4:20 PM EDT - 2 years ago

Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023

Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023

Sep 21, 2023, 8:25 PM EDT - 2 years ago

Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023

Aytu BioPharma to Present at LD Micro Main Event XVI Conference

Sep 13, 2023, 8:00 AM EDT - 2 years ago

Aytu BioPharma to Present at LD Micro Main Event XVI Conference

Aytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority

Jul 31, 2023, 8:00 AM EDT - 2 years ago

Aytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority

Aytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Jul 10, 2023, 8:00 AM EDT - 2 years ago

Aytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Aytu to Participate in the Maxim Group Virtual Healthcare Conference

Jun 14, 2023, 8:00 AM EDT - 2 years ago

Aytu to Participate in the Maxim Group Virtual Healthcare Conference

Aytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-Market

Jun 13, 2023, 1:45 PM EDT - 2 years ago

Aytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-Market

Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director

Jun 9, 2023, 8:00 AM EDT - 2 years ago

Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director

OptionSpark
OptionSpark Aug. 23 at 6:48 AM
$AYTU Aytu BioPharma Inc is a specialty pharma company with commercial execution challenges
0 · Reply
OptionSpark
OptionSpark Aug. 23 at 6:33 AM
$AYTU Aytu BioPharma Inc is a specialty pharma company with commercial execution challenges
0 · Reply
Alice_in_Dollarland
Alice_in_Dollarland Aug. 22 at 3:31 PM
$ELTP Upcoming catalysts include ANDA filing and FDA approval for a generic Eliquis ( the number #1 oral anticoagulant) prescribed globally. Last quarter's revenue was 40 million, an increase of 112% from a comparable quarter last year. Annual revenue 84 million, up 48 % from the last fiscal year. $AYTU $IINN $SIGA
0 · Reply
Alice_in_Dollarland
Alice_in_Dollarland Aug. 21 at 5:56 PM
$AYTU more interested in the drug for major depression.
0 · Reply
anotherbullrun
anotherbullrun Aug. 21 at 5:07 PM
$AYTU guys dont worry healight is coming soon
0 · Reply
Alice_in_Dollarland
Alice_in_Dollarland Aug. 21 at 4:57 PM
$AYTU Bearish board, but after looking over a couple of things...I'm in.
0 · Reply
redbugs
redbugs Aug. 16 at 2:26 AM
$AYTU Question please...I am not a shareholder of aytu having sold years ago as I saw this company was a dud going nowhere but down. However I am still holding in my fidelity account some CVRs related to the merger with Innovis. My understanding was these CVRs have expired. IS this true? If so why have they not been removed from my fidelity account?
1 · Reply
Alain_Simard
Alain_Simard Aug. 14 at 11:35 PM
$AYTU and there it is… AYTU is back to where it was a month ago… the only that sticks around here are dropping share prices
0 · Reply
Telorino
Telorino Aug. 12 at 3:45 PM
$AYTU POS only red in a sea of green… Everything ripping to ATH, except this mother f…er heading to R/S! You could literally throw a dart and pick anything better than A2! Where’re the pumpers?
0 · Reply
ZealTradingIsBack
ZealTradingIsBack Aug. 5 at 9:11 AM
$AYTU Used to be a holder from Covid Days and believed in Heal Light. Someone I know still holds and says they keep doing offerings. 🤷‍♂️ GLTA
0 · Reply
Chachix
Chachix Aug. 4 at 11:46 PM
$AYTU What this Poshit Criminal Fuck, Dishbrow is selling now? Scum Trash!!! This Crack Head do have even that Hair Paint as a Product Anymore!! J A I L!!!
0 · Reply
Dr_Stoxx
Dr_Stoxx Aug. 4 at 2:44 PM
$AYTU: LONG IN MY MOMENTUM LETTER.
0 · Reply
BuffTrader
BuffTrader Jul. 31 at 2:59 PM
$AYTU CEO Disbrow buys 77% more shares
3 · Reply
MagicalMichael
MagicalMichael Jul. 30 at 6:28 PM
$AYTU $SMCI $DPRO $SYM
0 · Reply
Dolphinsarecute
Dolphinsarecute Jul. 23 at 4:08 PM
$AYTU Hope you listened and went all in!
2 · Reply
LeopoldRothschild
LeopoldRothschild Jul. 23 at 3:48 PM
$AYTU Wow mexican villas for everybody!!!
0 · Reply
Chachix
Chachix Jul. 23 at 10:14 AM
$AYTU They have a UV light in the closet? 😂
0 · Reply
termoil
termoil Jul. 22 at 4:16 PM
$AYTU Nice breakthrough
0 · Reply
Chachix
Chachix Jul. 16 at 2:50 PM
$AYTU This Fraudster, Dishbrow, ain’t in Jail Yet? Continue To Scam Investors Since 2021? Hair Paint To Pretend to be Biopharma! Only On American Greed 2025 All Becomes Legal! Take a Slice and Pay The Price!!! ( for being stupid amd Invest in this Shithole)!!!
1 · Reply
stocksnewws
stocksnewws Jul. 15 at 6:14 PM
$MLGO It’s time to buy more. Tomorrow will be late ⏰ $MARA $GME $AYTU $HOLO
0 · Reply
SpencerF
SpencerF Jul. 15 at 12:04 PM
$AYTU still a chance the company could make it?
2 · Reply
WaspofWallStreet
WaspofWallStreet Jul. 14 at 6:46 PM
$AYTU increased position.
0 · Reply